Pandite, L., Metenou, S., Richardson, D. L., Hamilton, E., Le, L. V., Ma, B., . . . Offman, E. First-in-human phase I trial of the bispecific CD47 inhibitor and CD40 agonist Fc-fusion protein, SL-172154 in patients with platinum-resistant ovarian cancer. BMJ Publishing Group.
Chicago Style (17th ed.) CitationPandite, Lini, et al. First-in-human Phase I Trial of the Bispecific CD47 Inhibitor and CD40 Agonist Fc-fusion Protein, SL-172154 in Patients with Platinum-resistant Ovarian Cancer. BMJ Publishing Group.
MLA (9th ed.) CitationPandite, Lini, et al. First-in-human Phase I Trial of the Bispecific CD47 Inhibitor and CD40 Agonist Fc-fusion Protein, SL-172154 in Patients with Platinum-resistant Ovarian Cancer. BMJ Publishing Group.
Warning: These citations may not always be 100% accurate.